News
-
-
PRESS RELEASE
FY 2025: HelloFresh SE continues to show strong AEBITDA performance while efficiency program progresses meaningfully
HelloFresh SE reports strong AEBITDA performance in FY 2025, achieving €6.8 billion revenue with 14% yoy increase. Efficiency program on track, product investment program expanded for growth -
-
-
PRESS RELEASE
Blue Cap AG publishes preliminary financial figures for 2025: successful financial year 2025
Blue Cap AG reports successful financial year 2025 with EUR 129.1 million revenue and 5.5% adjusted EBITDA margin. Focus on Industrials and Business Services segments. Forecast for 2026 remains stable -
-
-
PRESS RELEASE
2025 annual results: strong improvement in financial earnings and cash-flows
Exail Technologies achieved significant financial growth in 2025 with record order intake of €844 million (+87%), revenue growth of +28%, and strengthened balance sheet post fundraising of €300 million. Operational milestones include delivering mine countermeasures to navies and increasing production capacity for navigation systems -
PRESS RELEASE
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
Sanofi's venglustat receives Breakthrough Therapy designation in the US for type 3 Gaucher disease, a rare lysosomal storage disorder. Positive results from the LEAP2MONO study show significant improvements in neurological symptoms -
PRESS RELEASE
Heidelberg Pharma to Receive Milestone Payment from Partner Huadong for Clinical Study with HDP-101 in China
Heidelberg Pharma to receive milestone payment from partner Huadong for clinical study with HDP-101 in China. First patient dosed in Phase I study evaluating safety, tolerability, and efficacy
